SHR-4298 Injection

· Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-4298 Injection, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors [Phase 1, Phase 2]